Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma - Test2 - elhamkhani - TriplyDB

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma

http://www.wikidata.org/entity/Q31111026

about

The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis.Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma.High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma.Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.Elevated Preoperative Serum Hs-CRP Level as a Prognostic Factor in Patients Who Underwent Resection for Hepatocellular Carcinoma Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma Causes of variation in the neutrophil-lymphocyte and platelet-lymphocyte ratios: a twin-family study.The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.An Easy and Useful Noninvasive Score Based on α-1-acid Glycoprotein and C-Reactive Protein for Diagnosis of Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection.Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective.Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation.Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer.Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib.Does neutrophil-to-lymphocyte ratio predict 1-year mortality in patients with primary biliary cholangitis? Results from a retrospective study with validation cohort.A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma.Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.

P2860

Q26745592-EAC3EA2B-47D7-4F2D-A7BE-E673EC3646AF Q26765926-C1463253-D252-4E05-BE9B-8CFA79C5F51C Q27005375-2421610D-A748-49C7-9B7C-C2703E8B2DC5 Q28241308-D02988BA-958C-4366-AAE6-5D1DF0E6DCAC Q33589014-2CC7CB00-E826-4DB2-8DC2-5860BCE9DE9F Q33762053-0D084D28-39EA-4521-88C2-919C6A73B627 Q33912315-C714F04F-03ED-4BB4-BD36-1EACA816B9B7 Q35128731-B7D62190-7F30-4B8C-93CA-E78B256E9A02 Q35161694-D1F22004-F779-4D16-902E-883F36103DA3 Q35651537-081BA4CF-8259-4304-A8EC-656F13EF32C8 Q35765404-B7F9D337-3973-44D2-A1A7-2016E8DE2781 Q35767923-02AE2CE7-21C9-4900-AA57-620087414434 Q35817001-C539EF30-058B-4025-BC98-D6A979D893C4 Q35820519-F5D1B8C5-1FD5-4793-80F2-3FF03998DED0 Q36052780-E65F4C06-DF78-4C7E-B54B-71B2F519E164 Q36145296-ACA389FD-3D94-48DC-9470-B2A4B9B3582A Q36232174-A3FDFCCB-E73B-495A-872A-2F195DED6A57 Q36414399-B491CAED-558F-4F46-9866-3ADFFC377225 Q37225990-C418F4F1-3C82-4562-86F4-DD7852B5962D Q37731958-CCEF9D5A-79A0-4048-88AD-57E3B04D39FD Q38377017-6881CEB1-C6C6-4960-8820-69656BB800EC Q38781597-049497E5-E204-4700-9D60-904E9964303B Q38933155-A8264434-DACC-4B6F-B1C3-E463F7673268 Q39324590-F78D1742-26F9-43F6-B1A4-66EE98DE3792 Q39333416-7D1862E3-A3F7-4F98-AE0D-907F70443C99 Q40404266-73A01620-09F8-44B5-8019-75F31C11AA80 Q41341293-473C935B-FA2E-4015-A68D-840DB1802033 Q41492181-D2E2C5D9-1992-4AD8-B7A0-A00F87208A1B Q41734066-4BE6EA52-5D5A-44EF-A469-3E4B9548C344 Q42042373-6D0E3E95-96AB-4241-93FD-2F4F2C633B23 Q46117374-4AC16E49-AF0C-45D8-A7AD-B667E39F41A9 Q47106977-95E7AFF8-DCD0-4DD9-B5C3-FCD9DD31F284 Q47135110-87665FD0-2D80-4705-93C4-4E92BCCDB271 Q48155735-42C4E408-3103-458D-B64A-51DFD0C4C608 Q48350251-178ED4C2-D3F0-4ED5-8402-1CF46CC040FB Q49674385-4E0632B5-A445-4E85-BA02-4B845D08151C Q51723701-15AB58D2-67AF-4980-8C0C-8DBD7927B914 Q52605888-25C2D5C6-0F20-46C1-B1A3-EE9AA8A9D4F7 Q52655169-6BDA5A87-A43A-4B2E-A17D-A489945595C8 Q52658496-5FCD2ECF-4A27-4B2B-B68C-CAA115D9B9DF

P2860

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma

http://www.wikidata.org/entity/Q31111026

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@ast

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@en

type

label

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@ast

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@en

prefLabel

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@ast

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@en

P1433

Q31111026-63F04B73-7938-4400-9740-B590EFF9B1E7

P1476

Q31111026-85E3DA04-9EF6-49A4-AE94-9B393292C481

P2093

Q31111026-34CBD05B-7080-4DFD-9192-0DE113BD6358

Q31111026-3BB31893-4135-4BF9-B213-A70952BB086E

Q31111026-65692017-445E-446B-9069-A7F030134FA4

Q31111026-A684A25D-BA73-430E-8450-9E26E62AC3D5

Q31111026-AB0B6EB1-6511-4273-B47F-30F8DE07198B

Q31111026-BDAC9072-D660-4C93-9C54-60C4008FE781

Q31111026-C5DD3DD9-92AD-4BD6-9E2B-6EF0417FE910

Q31111026-F4FE1963-B1C1-4260-96A3-A03AB5A44F21

P2860

Q31111026-00A16365-72D3-4CF7-BB80-C35A2A163705

Q31111026-0A153081-9B33-493C-9FF4-9CFF5EC2FD14

Q31111026-0D776266-3EC7-43E1-9CCB-540A97E18AD8

Q31111026-0EE565FB-3489-412F-A8E8-55CF574E54F5

Q31111026-1489EEED-3012-4D38-B17C-EC7E71573337

Q31111026-2C8D9FA2-01B9-4271-8041-8C807274D2C3

Q31111026-3E440DA7-E3E9-4922-BC22-A5C9FE0AF264

Q31111026-45735787-D190-4170-BCC6-EFAFDAE2F507

Q31111026-4CD34F67-CD9C-4720-8F26-84F5B9945C04

Q31111026-52BF24F6-1502-48B6-A595-EC06924EC6A2

P2888

Q31111026-FA47CC4E-F45A-4AC0-AD2B-728E1442AA0E

P304

Q31111026-08C7BCF5-F8D1-421A-A24D-93878DA40146

P31

Q31111026-10507CA6-E1F9-473F-9012-077A3DD7D747

P356

Q31111026-7A335AE2-44FB-428C-AA0C-018517F31C7C

P407

Q31111026-B5ADB276-B9AE-4C29-92E4-31F24040FA26

P478

Q31111026-ADA6B078-7958-4626-BA86-4133B274193D

P577

Q31111026-99386EFD-BC5A-4E10-B326-59E3423C45C1

P5875

Q31111026-15660664-295F-4EC9-97FB-766E8251CF16

P6179

Q31111026-365CD976-BE52-4E9F-BBEB-E6FCF92F518A

P698

Q31111026-45CA21AF-6862-46D2-9F04-F34738AFCDF7

P932

Q31111026-62F5AD5E-4597-4C40-B2CF-FBAC6CADE5FD

P356

1471-2407-13-78

P1433

P1476

Prognostic value of C-reactive ...... with hepatocellular carcinoma

@en

P2093

Byong Sun Oh

http://www.w3.org/2001/XMLSchema#string

Chan Ran You

http://www.w3.org/2001/XMLSchema#string

Chul Seung Kay

http://www.w3.org/2001/XMLSchema#string

Hyun Suk Jung

http://www.w3.org/2001/XMLSchema#string

Jeong Won Jang

http://www.w3.org/2001/XMLSchema#string

Jung Hyun Kwon

http://www.w3.org/2001/XMLSchema#string

Kyu Won Chung

http://www.w3.org/2001/XMLSchema#string

Seungok Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Hepatocellular carcinoma

Management of hepatocellular carcinoma

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer

The role of C-reactive protein as a prognostic indicator in advanced cancer.

The liver as the site of C-reactive protein formation.

The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.

C-reactive protein in liver cancer surgery.

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

P2888

1471-2407-13-78

P304

78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-78

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235627222

http://www.w3.org/2001/XMLSchema#string

P6179

1053388124

http://www.w3.org/2001/XMLSchema#string

P698

23409924

http://www.w3.org/2001/XMLSchema#string

P932

3584844

http://www.w3.org/2001/XMLSchema#string